StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) income statement

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3031% below fair value
$2.42−0.03 (-1.22%)

Close on Nov 20, 2026Market cap $138.39MP/E –Yield –

See a number that looks wrong?